2024 Q3 Form 10-Q Financial Statement
#000117891324002522 Filed on August 09, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
Revenue | $42.00K | $57.00K |
YoY Change | ||
Cost Of Revenue | $42.00K | $48.00K |
YoY Change | ||
Gross Profit | $0.00 | $9.000K |
YoY Change | ||
Gross Profit Margin | 0.0% | 15.79% |
Selling, General & Admin | $1.544M | $1.088M |
YoY Change | 49.9% | -4.14% |
% of Gross Profit | 12088.89% | |
Research & Development | $1.477M | $1.086M |
YoY Change | 7.81% | -10.17% |
% of Gross Profit | 12066.67% | |
Depreciation & Amortization | $11.00K | $11.00K |
YoY Change | 10.0% | -26.67% |
% of Gross Profit | 122.22% | |
Operating Expenses | $3.021M | $2.174M |
YoY Change | 26.61% | -6.7% |
Operating Profit | -$3.021M | -$2.165M |
YoY Change | 26.61% | -7.08% |
Interest Expense | $0.00 | $20.00K |
YoY Change | -100.0% | 300.0% |
% of Operating Profit | ||
Other Income/Expense, Net | $0.00 | $20.00K |
YoY Change | -100.0% | 300.0% |
Pretax Income | -$3.021M | -$2.145M |
YoY Change | 28.55% | -7.74% |
Income Tax | $0.00 | |
% Of Pretax Income | ||
Net Earnings | -$3.021M | -$2.145M |
YoY Change | 26.99% | -7.74% |
Net Earnings / Revenue | -7192.86% | -3763.16% |
Basic Earnings Per Share | $0.08 | $0.06 |
Diluted Earnings Per Share | $0.08 | $0.06 |
COMMON SHARES | ||
Basic Shares Outstanding | 36.32M shares | 35.79M shares |
Diluted Shares Outstanding | 37.64M shares | 37.09M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $6.915M | $9.056M |
YoY Change | -8.89% | -0.86% |
Cash & Equivalents | $6.915M | $9.056M |
Short-Term Investments | ||
Other Short-Term Assets | $89.00K | $67.00K |
YoY Change | -66.16% | -81.07% |
Inventory | ||
Prepaid Expenses | $147.0K | $268.0K |
Receivables | $42.00K | $57.00K |
Other Receivables | $69.00K | $69.00K |
Total Short-Term Assets | $7.340M | $9.595M |
YoY Change | -8.43% | -2.23% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $65.00K | $76.00K |
YoY Change | -39.81% | -37.7% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $20.00K | $20.00K |
YoY Change | 0.0% | -59.18% |
Total Long-Term Assets | $401.0K | $440.0K |
YoY Change | -26.96% | -30.27% |
TOTAL ASSETS | ||
Total Short-Term Assets | $7.340M | $9.595M |
Total Long-Term Assets | $401.0K | $440.0K |
Total Assets | $7.741M | $10.04M |
YoY Change | -9.62% | -3.93% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $184.0K | $69.00K |
YoY Change | -67.38% | -71.25% |
Accrued Expenses | $927.0K | $1.225M |
YoY Change | -36.51% | -24.62% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $1.111M | $1.294M |
YoY Change | -45.19% | -30.62% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $178.0K | $209.0K |
YoY Change | -40.67% | -39.94% |
Total Long-Term Liabilities | $178.0K | $209.0K |
YoY Change | -41.06% | -39.94% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $1.111M | $1.294M |
Total Long-Term Liabilities | $178.0K | $209.0K |
Total Liabilities | $1.289M | $1.503M |
YoY Change | -44.65% | -32.08% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$111.6M | -$108.5M |
YoY Change | 8.99% | 8.5% |
Common Stock | $118.0M | $117.0M |
YoY Change | 8.65% | 8.17% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $6.452M | $8.532M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $7.741M | $10.04M |
YoY Change | -9.62% | -3.93% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$3.021M | -$2.145M |
YoY Change | 26.99% | -7.74% |
Depreciation, Depletion And Amortization | $11.00K | $11.00K |
YoY Change | 10.0% | -26.67% |
Cash From Operating Activities | -$2.154M | -$1.335M |
YoY Change | 41.71% | -14.37% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $0.00 | $0.00 |
YoY Change | -100.0% | |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | $0.00 | $0.00 |
YoY Change | -100.0% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 13.00K | 1.216M |
YoY Change | 24220.0% | |
NET CHANGE | ||
Cash From Operating Activities | -2.154M | -1.335M |
Cash From Investing Activities | 0.000 | 0.000 |
Cash From Financing Activities | 13.00K | 1.216M |
Net Change In Cash | -2.141M | -119.0K |
YoY Change | 40.86% | -92.35% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$2.154M | -$1.335M |
Capital Expenditures | $0.00 | $0.00 |
Free Cash Flow | -$2.154M | -$1.335M |
YoY Change | 41.71% | -14.42% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q2 | us-gaap |
Assets
Assets
|
10035000 | usd |
CY2024Q2 | us-gaap |
Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
|
30000 | usd |
CY2023Q4 | us-gaap |
Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
|
32000 | usd |
CY2024Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
209000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-104386000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11765000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4162000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-14000 | usd | |
CY2024Q2 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
166000 | usd |
CY2023Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
159000 | usd |
CY2024Q2 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
260000 | usd |
CY2023Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
215000 | usd |
CY2024Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
644000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
500000 | usd |
CY2024Q2 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
1070000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
874000 | usd |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9056000 | usd |
CY2023Q4 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
6000 | usd |
CY2023Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
508000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
83000 | usd |
CY2024Q2 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
1070000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
874000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1091000 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
117038000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
114730000 | usd |
CY2024Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
41000 | usd |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
41000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8532000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4515000 | usd | |
us-gaap |
Depreciation
Depreciation
|
24000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1062000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
988000 | usd | |
entx |
Finance Expenses Net
FinanceExpensesNet
|
-14000 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
356000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3197000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3168000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1951000 | usd | |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9056000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11257000 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
76000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
100000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
1379000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10386000 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10035000 | usd |
entx |
Finance Expenses Net
FinanceExpensesNet
|
-6000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-217000 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
232000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
196000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
252000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
12000 | usd | |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
9595000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
11765000 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
69000 | usd |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
36913725 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
28811162 | shares | |
us-gaap |
Depreciation
Depreciation
|
29000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3175000 | usd | |
CY2023Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
66000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
179000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
256000 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-108548000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4162000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4515000 | usd | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.11 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.16 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
36913725 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
28811162 | shares | |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9201000 | usd |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9135000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
78000 | usd |
entx |
Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities
RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
|
33000 | usd | |
entx |
Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities
RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
|
449000 | usd | |
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
344000 | usd |
CY2024Q2 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
6000 | usd |
CY2024Q2 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
440000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2140000 | usd | |
us-gaap |
Other Nonrecurring Income
OtherNonrecurringIncome
|
27000 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
4236000 | usd | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10386000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4162000 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1062000 | usd | |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8532000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11754000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4515000 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
988000 | usd | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8232000 | usd |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
223000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1246000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5000 | usd | |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9134000 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
268000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
34000 | usd |
CY2024Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
67000 | usd |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
69000 | usd |
CY2024Q2 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
14000 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
1503000 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
482000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
238000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
388000 | usd |
CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
288000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1821000 | usd | |
us-gaap |
Other Nonrecurring Income
OtherNonrecurringIncome
|
0 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
65000 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
27000 | usd | |
entx |
Exercise Of Warrants Value
ExerciseOfWarrantsValue
|
90000 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
0 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
57000 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11085000 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9134000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9201000 | usd |
entx |
Interest Received
InterestReceived
|
66000 | usd | |
entx |
Interest Received
InterestReceived
|
0 | usd | |
CY2024Q2 | entx |
Advance Income Tax
AdvanceIncomeTax
|
69000 | usd |
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
9112002 | ||
dei |
Trading Symbol
TradingSymbol
|
ENTX | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
CY2024Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
36324579 | shares |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11019000 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
57000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
14000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
155000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
134000 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1294000 | usd |
CY2024Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
us-gaap |
Revenues
Revenues
|
57000 | usd | |
us-gaap |
Revenues
Revenues
|
0 | usd | |
CY2024Q2 | us-gaap |
Revenues
Revenues
|
57000 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
0 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
48000 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | usd | |
CY2024Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
48000 | usd |
CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | usd |
us-gaap |
Gross Profit
GrossProfit
|
9000 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
0 | usd | |
CY2024Q2 | us-gaap |
Gross Profit
GrossProfit
|
9000 | usd |
CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
0 | usd |
CY2024Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1086000 | usd |
CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1209000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2415000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2429000 | usd | |
CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1088000 | usd |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1135000 | usd |
CY2024Q2 | us-gaap |
Other Nonrecurring Income
OtherNonrecurringIncome
|
0 | usd |
CY2023Q2 | us-gaap |
Other Nonrecurring Income
OtherNonrecurringIncome
|
14000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
4542000 | usd | |
CY2024Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2174000 | usd |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2330000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4227000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4542000 | usd | |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2165000 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2330000 | usd |
CY2024Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
20000 | usd |
CY2023Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
5000 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2145000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2325000 | usd |
CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.06 | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.08 | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
37090160 | shares |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
37090160 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
28812375 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
28812375 | shares |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
555000 | usd | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
601000 | usd | |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8863000 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2145000 | usd |
CY2024Q2 | entx |
Exercise Of Warrants Value
ExerciseOfWarrantsValue
|
60000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
555000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
601000 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
0 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
598000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8532000 | usd |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
5000 | usd | |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10080000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2325000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
5000 | usd |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
472000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8232000 | usd |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-12000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
601000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
5000 | usd | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
555000 | usd | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
90000 | usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | usd | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12376000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
CY2023Q4 | entx |
Advance Income Tax
AdvanceIncomeTax
|
69000 | usd |
CY2024Q2 | entx |
Restricted Deposits
RestrictedDeposits
|
78000 | usd |
CY2023Q4 | entx |
Restricted Deposits
RestrictedDeposits
|
66000 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
482000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
238000 | usd |
us-gaap |
Revenues
Revenues
|
57000 | usd | |
ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false |